Åslaug Helland

Professor II - Forskningsleder KRE
Bilde av Åslaug Helland
English version of this page
Brukernavn
Besøksadresse Forskningsveien 2 A OUS Rikshospitalet 0372 Oslo
Postadresse Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo
Andre tilknytninger Kreftklinikken

Publikasjoner

  • Berg, Janna; Ramberg, Christina; Haugstvedt, Jon Olav Sulheim; Bengtson, May-Bente; Gabrielsen, Anne Marie & Brustugun, Odd [Vis alle 8 forfattere av denne artikkelen] (2021). Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers. Frontiers in Oncology. ISSN 2234-943X. 11. doi: 10.3389/fonc.2021.674731. Fulltekst i vitenarkiv
  • Öjlert, Åsa Kristina; Nebdal, Daniel; Snapkov, Igor; Olsen, Vibeke; Kidman, Joel & Greiff, Victor [Vis alle 8 forfattere av denne artikkelen] (2021). Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor. Molecular Oncology. ISSN 1574-7891. s. 1–11. doi: 10.1002/1878-0261.13082.
  • Bjaanæs, Maria Moksnes; Nilsen, Gro; Halvorsen, Ann Rita; Russnes, Hege Elisabeth Giercksky; Solberg, Steinar & Jørgensen, Lars [Vis alle 9 forfattere av denne artikkelen] (2021). Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors. BMC Cancer. ISSN 1471-2407. 21(1). doi: 10.1186/s12885-021-08811-7.
  • Lehtiö, Janne; Arslan, Taner; Siavelis, Ioannis; Pan, Yanbo; Socciarelli, Fabio & Berkovska, Olena [Vis alle 29 forfattere av denne artikkelen] (2021). Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. Cancer. ISSN 0008-543X. doi: 10.1038/s43018-021-00259-9.
  • Popat, Sanjay; Brustugun, Odd; Cadranel, Jacques; Felip, Enriqueta; Garassino, Marina Chiara & Griesinger, Frank [Vis alle 12 forfattere av denne artikkelen] (2021). Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer. Lung Cancer. ISSN 0169-5002. 157, s. 9–16. doi: 10.1016/j.lungcan.2021.05.017. Fulltekst i vitenarkiv
  • Eide, Inger Johanne Zwicky; Grut, Harald; Helland, Åslaug; Ekman, Simon; Sørensen, Jens Benn & Hansen, Karin Holmskov [Vis alle 11 forfattere av denne artikkelen] (2021). Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study. Acta Oncologica. ISSN 0284-186X. doi: 10.1080/0284186X.2021.1973092.
  • Abravan, Azadeh; Eide, Hanne Astrid; Helland, Åslaug & Malinen, Eirik (2020). Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy. Clinical and Translational Radiation Oncology. ISSN 2405-6308. 22, s. 15–21. doi: 10.1016/j.ctro.2020.02.005. Fulltekst i vitenarkiv
  • Liu, Jingjing; van der Smissen, Wendy J. C. Prager; Collee, Margriet J.; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Vis alle 82 forfattere av denne artikkelen] (2020). Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. ISSN 2045-2322. 10:9688(1), s. 1–14. doi: 10.1038/s41598-020-65665-y. Fulltekst i vitenarkiv
  • Stankovic, Branislava; Aamodt, Henrik; Bjørhovde, Heidi Anine Korsmo; Müller, Elisabeth; Hammarström, Clara Louise & Brustugun, Odd Terje [Vis alle 9 forfattere av denne artikkelen] (2020). The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases. Scandinavian Journal of Immunology. ISSN 0300-9475. 92:e12893(2), s. 1–12. doi: 10.1111/sji.12893. Fulltekst i vitenarkiv
  • Haakensen, Vilde Drageset; Khadse, Anand; Sandhu, Vandana; Halvorsen, Ann Rita; Solberg, Steinar & Jørgensen, Lars Hilmar [Vis alle 9 forfattere av denne artikkelen] (2020). Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy. International Journal of Cancer. ISSN 0020-7136. 147(10), s. 2957–2966. doi: 10.1002/ijc.33121. Fulltekst i vitenarkiv
  • Kramer, Iris; Hooning, Maartje J.; Mavaddat, Nasim; Hauptmann, Michael; Keeman, Renske & Steyerberg, Ewout W. [Vis alle 54 forfattere av denne artikkelen] (2020). Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. American Journal of Human Genetics. ISSN 0002-9297. 107(5), s. 837–848. doi: 10.1016/j.ajhg.2020.09.001.
  • Zhang, Ruyang; Chen, Chao; Dong, Xuesi; Shen, Sipeng; Lai, Linjing & He, Jieyu [Vis alle 30 forfattere av denne artikkelen] (2020). Independent validation of early-stage non-small cell lung cancer prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects. Chest. ISSN 0012-3692. 158(2), s. 808–819. doi: 10.1016/j.chest.2020.01.048. Fulltekst i vitenarkiv
  • Ji, Xinyu; Lin, Lijuan; Shen, Sipeng; Dong, Xuesi; Chen, Chao & Li, Yi [Vis alle 29 forfattere av denne artikkelen] (2020). Epigenetic–smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients. Molecular Oncology. ISSN 1574-7891. 14(11), s. 2759–2774. doi: 10.1002/1878-0261.12785. Fulltekst i vitenarkiv
  • Chen, Chao; Wei, Yongyue; Wei, Liangmin; Chen, Jiajin; Chen, Xin & Dong, Xuesi [Vis alle 27 forfattere av denne artikkelen] (2020). Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients. Aging. ISSN 1945-4589. 12(11), s. 10642–10662. doi: 10.18632/aging.103284. Fulltekst i vitenarkiv
  • Nilsen, Line Brennhaug; Digernes, Ingrid; Grøvik, Endre; Saxhaug, Cathrine; Latysheva, Anna & Geier, Oliver [Vis alle 11 forfattere av denne artikkelen] (2020). Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases. Neuro-Oncology Advances (NOA). 2(1). doi: 10.1093/noajnl/vdaa028. Fulltekst i vitenarkiv
  • Frafjord, Astri; Skarshaug, Renate; Hammarström, Clara Louise; Stankovic, Branislava; Dorg, Linda Trobe & Aamodt, Henrik [Vis alle 11 forfattere av denne artikkelen] (2020). Antibody combinations for optimized staining of macrophages in human lung tumours. Scandinavian Journal of Immunology. ISSN 0300-9475. 92:e12889(1), s. 1–24. doi: 10.1111/sji.12889. Fulltekst i vitenarkiv
  • Eide, Inger Johanne; Helland, Åslaug; Ekman, Simon; Mellemgaard, Anders; Hansen, Karin Holmskov & Cicenas, Saulius [Vis alle 9 forfattere av denne artikkelen] (2020). Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study). Lung Cancer. ISSN 0169-5002. 143, s. 27–35. doi: 10.1016/j.lungcan.2020.03.009. Fulltekst i vitenarkiv
  • Øjlert, Åsa Kristina; Nebdal, Daniel J.H.; Lund-Iversen, Marius; Ellefsen, Renée Åstrøm; Brustugun, Odd Terje & Gran, Jon Michael [Vis alle 8 forfattere av denne artikkelen] (2020). Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer–predictors of response and impact of previous radiotherapy. Acta Oncologica. ISSN 0284-186X. s. 1–9. doi: 10.1080/0284186X.2020.1854851. Fulltekst i vitenarkiv
  • Halvorsen, Ann Rita; Haugen, Mads Haugland; Øjlert, Åsa Kristina; Lund-Iversen, Marius; Jørgensen, Lars Hilmar & Solberg, Steinar [Vis alle 9 forfattere av denne artikkelen] (2020). Protein kinase C isozymes associated with relapse free survival in non-small cell lung cancer patients. Frontiers in Oncology. ISSN 2234-943X. 10:590755, s. 1–11. doi: 10.3389/fonc.2020.590755. Fulltekst i vitenarkiv
  • Digernes, Ingrid; Nilsen, Line; Grøvik, Endre; Bjørnerud, Atle; Løvland, Grethe & Vik-Mo, Einar O. [Vis alle 12 forfattere av denne artikkelen] (2020). Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI. Physics in Medicine and Biology. ISSN 0031-9155. 65(22). doi: 10.1088/1361-6560/abb71a. Fulltekst i vitenarkiv
  • Halvorsen, Ann Rita; Aure, Miriam Ragle; Øjlert, Åsa Kristina; Brustugun, Odd Terje; Solberg, Steinar & Nebdal, Daniel J.H. [Vis alle 7 forfattere av denne artikkelen] (2019). Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC. Molecular Oncology. ISSN 1574-7891. doi: 10.1002/1878-0261.12571. Fulltekst i vitenarkiv
  • Nygård, Ståle; Lingjærde, Ole Christian; Caldas, Carlos; Hovig, Eivind; Børresen-Dale, Anne-Lise & Helland, Åslaug [Vis alle 7 forfattere av denne artikkelen] (2019). PathTracer: High-sensitivity detection of differential pathway activity in tumours. Scientific Reports. ISSN 2045-2322. 9:16332, s. 1–8. doi: 10.1038/s41598-019-52529-3. Fulltekst i vitenarkiv
  • Umu, Sinan Uğur; Langseth, Hilde; Keller, Andreas; Meese, Eckart; Helland, Åslaug & Lyle, Robert [Vis alle 7 forfattere av denne artikkelen] (2019). A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis. Molecular Oncology. ISSN 1574-7891. 14(2), s. 235–247. doi: 10.1002/1878-0261.12620.
  • Shao, Borong; Bjaanæs, Maria Moksnes; Helland, Åslaug; Schütte, Christof & Conrad, Tim (2019). EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma. PLOS ONE. ISSN 1932-6203. 14:e0204186(1), s. 1–20. doi: 10.1371/journal.pone.0204186. Fulltekst i vitenarkiv
  • Zhang, Ruyang; Lai, Linjing; He, Jieyu; Chen, Chao; You, Dongfang & Duan, Weiwei [Vis alle 24 forfattere av denne artikkelen] (2019). EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC. Epigenetics. ISSN 1559-2294. 14(2), s. 118–129. doi: 10.1080/15592294.2019.1573066.
  • Øjlert, Åsa Kristina; Halvorsen, Ann Rita; Nebdal, Daniel J.H.; Lund-Iversen, Marius; Solberg, Steinar & Brustugun, Odd Terje [Vis alle 8 forfattere av denne artikkelen] (2019). The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery. Molecular Oncology. ISSN 1574-7891. 13(5), s. 1166–1179. doi: 10.1002/1878-0261.12475. Fulltekst i vitenarkiv
  • Solberg, Steinar; Nilssen, Yngvar; Brustugun, Odd Terje; Grimsrud, Tom Kristian; Haram, Per Magnus & Helbekkmo, Nina [Vis alle 15 forfattere av denne artikkelen] (2019). Increase in curative treatment and survival of lung cancer in Norway 2001-2016. European Journal of Epidemiology (EJE). ISSN 0393-2990. 34(10), s. 951–955. doi: 10.1007/s10654-019-00536-z. Fulltekst i vitenarkiv
  • Zhang, Ruyang; Lai, Linjing; Dong, Xuesi; He, Jieyu; You, Dongfang & Chen, Chao [Vis alle 27 forfattere av denne artikkelen] (2019). SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysis. Molecular Oncology. ISSN 1574-7891. 13(5), s. 1235–1248. doi: 10.1002/1878-0261.12482. Fulltekst i vitenarkiv
  • Dong, Xuesi; Zhang, Ruyang; He, Jieyu; Lai, Linjing; Alolga, Raphael N. & Shen, Sipeng [Vis alle 26 forfattere av denne artikkelen] (2019). Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma. Aging. ISSN 1945-4589. 11(16), s. 6312–6335. doi: 10.18632/aging.102189. Fulltekst i vitenarkiv
  • Bergholtz, Helga; Lien, Tonje Gulbrandsen; Ursin, Giske; Holmen, Marit Muri; Helland, Åslaug & Sørlie, Therese [Vis alle 7 forfattere av denne artikkelen] (2019). A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue. Journal of mammary gland biology and neoplasia. ISSN 1083-3021. 24(2), s. 163–175. doi: 10.1007/s10911-018-09423-x. Fulltekst i vitenarkiv
  • Nilsen, Line; Grøvik, Endre; Digernes, Ingrid; Saxhaug, Cathrine; Latysheva, Anna & Geier, Oliver [Vis alle 12 forfattere av denne artikkelen] (2019). Vascular responses in normal brain tissue after combined immunotherapy and SRS to brain metastases. Radiotherapy and Oncology. ISSN 0167-8140. 133, s. 551–552. doi: 10.1016/S0167-8140%2819%2931420-3.
  • Wei, Youngyue; Liang, Junya; Zhang, Ruyang; Guo, Yichen; Shen, Sipeng & Su, Li [Vis alle 18 forfattere av denne artikkelen] (2018). Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC. Clinical Epigenetics. ISSN 1868-7075. 10(41), s. 1–11. doi: 10.1186/s13148-018-0474-3.
  • Novello, Silvia; Mazieres, Julien; Oh, In-Jae; de Castro, Javier Mayor; Migliorino, Maria Rita & Helland, Åslaug [Vis alle 15 forfattere av denne artikkelen] (2018). Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study. Annals of Oncology. ISSN 0923-7534. 29(6), s. 1409–1416. doi: 10.1093/annonc/mdy121.
  • Brustugun, Odd Terje; Grønberg, Bjørn Henning; Fjellbirkeland, Lars; Helbekkmo, Nina; Aanerud, Marianne & Grimsrud, Tom Kristian [Vis alle 11 forfattere av denne artikkelen] (2018). Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016. Lung Cancer. ISSN 0169-5002. 122, s. 138–145. doi: 10.1016/j.lungcan.2018.06.003. Fulltekst i vitenarkiv
  • Guo, Yichen; Zhang, Ruyang; Shen, Sipeng; Wei, Yongyue; Salama, Sebastian Moran & Fleischer, Thomas [Vis alle 15 forfattere av denne artikkelen] (2018). DNA methylation of LRRC3B: A biomarker for survival of early-stage non-small cell lung cancer patients. Cancer Epidemiology, Biomarkers and Prevention. ISSN 1055-9965. 27(12), s. 1527–1535. doi: 10.1158/1055-9965.EPI-18-0454. Fulltekst i vitenarkiv
  • Eide, Hanne Astrid; Knudtsen, Ingerid Skjei; Sandhu, Vandana; Løndalen, Ayca; Halvorsen, Ann Rita & Abravan, Azadeh [Vis alle 12 forfattere av denne artikkelen] (2018). Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy. Advances in Radiation Oncology. ISSN 2452-1094. 3(2), s. 130–138. doi: 10.1016/j.adro.2017.12.007. Fulltekst i vitenarkiv
  • Berg, Janna; Halvorsen, Ann Rita; Bengtson, May-Bente; Tasken, Kristin Austlid; Mælandsmo, Gunhild Mari & Yndestad, Arne [Vis alle 11 forfattere av denne artikkelen] (2018). Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. BMC Cancer. ISSN 1471-2407. 18(1). doi: 10.1186/s12885-018-4659-0.
  • Gandara, David R.; von Pawel, Joachim; Mazieres, Julien; Sullivan, Richard; Helland, Åslaug & Han, Ji-Youn [Vis alle 20 forfattere av denne artikkelen] (2018). Atezolizumab treatment beyond progression in advanced NSCLC: Results from the randomized, phase III OAK Study. Journal of Thoracic Oncology. ISSN 1556-0864. 13(12), s. 1906–1918. doi: 10.1016/j.jtho.2018.08.2027. Fulltekst i vitenarkiv
  • George, Julie; Walter, Vonn; Peifer, Martin; Alexandrov, Ludmil B.; Seidel, Danila & Leenders, Frauke [Vis alle 62 forfattere av denne artikkelen] (2018). Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nature Communications. ISSN 2041-1723. 9:1048, s. 1–13. doi: 10.1038/s41467-018-03099-x. Fulltekst i vitenarkiv
  • Halvorsen, Ann Rita; Sandhu, Vandana; Sprauten, Mette; Flote, Vidar Gordon; Kure, Elin Wenche Hegland & Brustugun, Odd Terje [Vis alle 7 forfattere av denne artikkelen] (2018). Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab. Acta Oncologica. ISSN 0284-186X. 57(9), s. 1225–1231. doi: 10.1080/0284186X.2018.1465585. Fulltekst i vitenarkiv
  • Digernes, Ingrid; Grøvik, Endre; Nilsen, Line; Saxhaug, Cathrine; Geier, Oliver & Reitan, Edmund [Vis alle 12 forfattere av denne artikkelen] (2018). Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery. Advances in Radiation Oncology. ISSN 2452-1094. 3, s. 559–567. doi: 10.1016/j.adro.2018.05.005.
  • Abravan, Azadeh; Eide, Hanne Astrid; Løndalen, Ayca; Helland, Åslaug & Malinen, Eirik (2018). Mapping bone marrow response in the vertebral column by positron emission tomography following radiotherapy and erlotinib therapy of lung cancer. Molecular Imaging and Biology. ISSN 1536-1632. 21(2), s. 391–398. doi: 10.1007/s11307-018-1226-7.
  • Rye, Inga Hansine; Trinh, Anne; Sætersdal, Anna Barbro; Nebdal, Daniel J.H.; Lingjærde, Ole Christian & Almendro, Vanessa [Vis alle 11 forfattere av denne artikkelen] (2018). Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors. Molecular Oncology. ISSN 1574-7891. s. 1–18. doi: 10.1002/1878-0261.12375. Fulltekst i vitenarkiv
  • Stankovic, Branislava; Bjørhovde, Heidi Anine Korsmo; Skarshaug, Renate; Aamodt, Henrik; Frafjord, Astri & Müller, Elisabeth [Vis alle 14 forfattere av denne artikkelen] (2018). Immune Cell Composition in Human Non-small Cell Lung Cancer. Frontiers in Immunology. ISSN 1664-3224. Feb(1), s. 1–21. doi: 10.3389/fimmu.2018.03101. Fulltekst i vitenarkiv
  • Shen, Sipeng; Zhang, Ruyang; Guo, Yichen; Loehrer, Elizabeth; Wei, Yongyue & Zhu, Ying [Vis alle 18 forfattere av denne artikkelen] (2018). A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer. Molecular Oncology. ISSN 1574-7891. 12(6), s. 913–924. doi: 10.1002/1878-0261.12204. Fulltekst i vitenarkiv
  • Terkelsen, Thilde; Haakensen, Vilde Drageset; Saldova, Radka; Gromov, Pavel; Hansen, Merete Kjær & Stockmann, Henning [Vis alle 12 forfattere av denne artikkelen] (2018). N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome. Molecular Oncology. ISSN 1574-7891. 12(6), s. 972–990. doi: 10.1002/1878-0261.12312.
  • Abravan, Azadeh; Eide, Hanne Astrid; Knudtsen, Ingerid Skjei; Løndalen, Ayca; Helland, Åslaug & Malinen, Eirik (2017). Assessment of pulmonary 18F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib. Clinical and Translational Radiation Oncology. ISSN 2405-6308. 4, s. 57–63. doi: 10.1016/j.ctro.2017.04.002.
  • Halvorsen, Ann Rita; Kristensen, Gunnar S Balle; Embleton, Andrew; Adusei, Cybil; Barretina-Ginesta, Maria Pilar & Beale, Philip [Vis alle 7 forfattere av denne artikkelen] (2017). Evaluation of prognostic and predictive significance of circulating MicroRNAs in ovarian cancer patients. Disease Markers. ISSN 0278-0240. 2017:3098542, s. 1–9. doi: 10.1155/2017/3098542.
  • Planchard, David; Smit, Egbert F; Groen, Harry J. M.; Mazieres, Julien; Besse, Benjamin & Helland, Åslaug [Vis alle 11 forfattere av denne artikkelen] (2017). Dabrafenib plus trametinib in patients with previously untreated BRAF<sup>V600E</sup>-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial. The Lancet Oncology. ISSN 1470-2045. 18(10), s. 1307–1316. doi: 10.1016/S1470-2045%2817%2930679-4.
  • Mcgowan, Marc Kevin; Kleinberg, Lilach; Halvorsen, Ann Rita; Helland, Åslaug & Brustugun, Odd Terje (2017). NSCLC depend upon YAP expression and nuclear localization after acquiring resistance to EGFR inhibitors. Genes & cancer. ISSN 1947-6019. 8(3-4), s. 497–504. doi: 10.18632/genesandcancer.136. Fulltekst i vitenarkiv
  • Abravan, Azadeh; Knudtsen, Ingerid Skjei; Eide, Hanne Astrid; Løndalen, Ayca; Helland, Åslaug & van Luijk, Peter [Vis alle 7 forfattere av denne artikkelen] (2017). A new method to assess pulmonary changes using 18F-fluoro-2-deoxyglucose positron emission tomography for lung cancer patients following radiotherapy. Acta Oncologica. ISSN 0284-186X. 56(11), s. 1597–1603. doi: 10.1080/0284186X.2017.1349336.
  • dannenfelser, ruth; Nome, Marianne Eikhom; Tahiri, Andliena; Ursini-Siegel, Josie; Vollan, Hans Kristian Moen & Haakensen, Vilde Drageset [Vis alle 12 forfattere av denne artikkelen] (2017). Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity. OncoTarget. ISSN 1949-2553. 8(34), s. 57121–57133. doi: 10.18632/oncotarget.19078. Fulltekst i vitenarkiv
  • Helland, Åslaug; Brustugun, Odd Terje; Nakken, Sigve; Halvorsen, Ann Rita; Dønnem, Tom & Bremnes, Roy M. [Vis alle 15 forfattere av denne artikkelen] (2017). High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival. International Journal of Cancer. ISSN 0020-7136. 141(1), s. 184–190. doi: 10.1002/ijc.30726. Fulltekst i vitenarkiv
  • Brustugun, Odd Terje; Sprauten, Mette & Helland, Åslaug (2017). Real-world data on nivolumab treatment of non-small cell lung cancer. Acta Oncologica. ISSN 0284-186X. 56(3), s. 438–440. doi: 10.1080/0284186X.2016.1253865.
  • Fleischer, Thomas; Klajic, Jovana; Aure, Miriam Ragle; Louhimo, Riku; Pladsen, Arne Valebjørg & Ottestad, Lars [Vis alle 18 forfattere av denne artikkelen] (2016). DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival. OncoTarget. ISSN 1949-2553. 8(1), s. 1074–1082. doi: 10.18632/oncotarget.13718.
  • Eide, Hanne Astrid; Halvorsen, Ann Rita; Bjaanæs, Maria Moksnes; Piri, Hossein; Holm, Ruth & Solberg, Steinar [Vis alle 10 forfattere av denne artikkelen] (2016). The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma-differences in histological subtypes. BMC Cancer. ISSN 1471-2407. 16(1). doi: 10.1186/s12885-016-2104-9.
  • Joly-Battaglini, Albane; Hammarström, Clara Louise; Stankovic, Branislava; Aamodt, Henrik; Stjärne, Johan Folke Håkan & Brustugun, Odd Terje [Vis alle 9 forfattere av denne artikkelen] (2016). Rituximab efficiently depletes B cells in lung tumors and normal lung tissue. F1000. ISSN 1759-796X. 5. doi: 10.12688/f1000research.7599.1.
  • Haakensen, Vilde Drageset; Nygaard, Vegard; Greger, Liliana; Aure, Miriam Ragle; Fromm, Bastian & Bukholm, Ida Rashida Khan [Vis alle 15 forfattere av denne artikkelen] (2016). Subtype-specific micro-RNA expression signatures in breast cancer progression. International Journal of Cancer. ISSN 0020-7136. 139(5), s. 1117–1128. doi: 10.1002/ijc.30142.
  • Halvorsen, Ann Rita; Helland, Åslaug; Gromov, Pavel; Wielenga, Vera Timmermans; Talman, Maj-Lis Møller & Brünner, Nils [Vis alle 10 forfattere av denne artikkelen] (2016). Profiling of microRNAs in tumor interstitial fluid of breasttumors – a novel resource to identify biomarkers forprognostic classification and detection of cancer. Molecular Oncology. ISSN 1574-7891. 11, s. 220–234. doi: 10.1002/1878-0261.12025. Fulltekst i vitenarkiv
  • Jaime A, Espinoza; Jabeen, Shakila; Batra, Richa; Papaleo, Elena; Haakensen, Vilde Drageset & Wielenga, Vera Timmermans [Vis alle 13 forfattere av denne artikkelen] (2016). Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology. ISSN 2162-4011. 5(12). doi: 10.1080/2162402X.2016.1248015.
  • Mcgowan, Marc Kevin; Hoven, Aleksandra Silye; Lund-Iversen, Marius; Solberg, Steinar; Helland, Åslaug & Hirsch, Fred R [Vis alle 7 forfattere av denne artikkelen] (2016). PIK3CA mutations as prognostic factor in squamous cell lung carcinoma. Lung Cancer. ISSN 0169-5002. 103, s. 52–57. doi: 10.1016/j.lungcan.2016.11.018.
  • Weischenfeldt, Joachim; Dubash, Taronish; Drainas, Alexandros P.; Mardin, Balca R.; Chen, Yuanyuan & Stütz, Adrian M. [Vis alle 32 forfattere av denne artikkelen] (2016). Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nature Genetics. ISSN 1061-4036. 49(1), s. 65–74. doi: 10.1038/ng.3722.
  • Berg, Janna; Fjellbirkeland, Lars; Suhrke, Pål; Jebsen, Peter Wilhelm; Lund-Iversen, Marius & Kleinberg, Lilach [Vis alle 9 forfattere av denne artikkelen] (2016). EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust. Acta Oncologica. ISSN 0284-186X. 55(2), s. 149–155. doi: 10.3109/0284186X.2015.1062537.
  • Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Richardsen, Elin; Paulsen, Erna-Elise & Hald, Sigurd [Vis alle 21 forfattere av denne artikkelen] (2016). Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Annals of Oncology. ISSN 0923-7534. 27(2), s. 225–232. doi: 10.1093/annonc/mdv560.
  • Bjaanæs, Maria Moksnes; Fleischer, Thomas; Halvorsen, Ann Rita; Daunay, Antoine; Busato, Florence & Solberg, Steinar [Vis alle 14 forfattere av denne artikkelen] (2016). Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis. Molecular Oncology. ISSN 1574-7891. 10(2), s. 330–343. doi: 10.1016/j.molonc.2015.10.021.
  • Halvorsen, Ann Rita; Silwal-Pandit, Laxmi; Meza, Leonardo Zepeda; Vodak, Daniel; Vu, Phuong Ngoc Thi & Sagerup, Camilla Maria Troøien [Vis alle 11 forfattere av denne artikkelen] (2016). TP53 mutation spectrum in smokers and never smoking lung cancer patients. Frontiers in Genetics. ISSN 1664-8021. 7(MAY). doi: 10.3389/fgene.2016.00085.
  • Rud, Ane Kristine Kongsgaard; Pedersen, Kjetil Boye; Fodstad, Øystein; Juell, Siri; Jørgensen, Lars Hilmar & Solberg, Steinar [Vis alle 9 forfattere av denne artikkelen] (2016). Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer. Diagnostic Pathology. ISSN 1746-1596. 11(50). doi: 10.1186/s13000-016-0504-4. Fulltekst i vitenarkiv
  • Easton, Douglas F; Lesueur, Fabienne; Decker, Brennan; Michailidou, Kyriaki; Li, Jun & Allen, Jamie [Vis alle 149 forfattere av denne artikkelen] (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: Implications for gene panel testing. Journal of Medical Genetics. ISSN 0022-2593. 53(5), s. 298–309. doi: 10.1136/jmedgenet-2015-103529.
  • Dunning, Alison M.; Michailidou, Kyriaki; Kuchenbaecker, Karoline B.; Thompson, Deborah; French, Juliet D. & Beesley, Jonathan [Vis alle 248 forfattere av denne artikkelen] (2016). Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature Genetics. ISSN 1061-4036. 48(4), s. 374–386. doi: 10.1038/ng.3521.
  • Eide, Hanne Astrid; Halvorsen, Ann Rita; Sandhu, Vandana; Fåne, Anne; Berg, Janna & Haakensen, Vilde Drageset [Vis alle 11 forfattere av denne artikkelen] (2016). Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease. Clinical & translational immunology. ISSN 2050-0068. 5. doi: 10.1038/cti.2016.65. Fulltekst i vitenarkiv
  • Halvorsen, Ann Rita; Bjaanæs, Maria Moksnes; LeBlanc, Marissa; Holm, Are Martin; Bolstad, Nils & Rubio, Luis [Vis alle 12 forfattere av denne artikkelen] (2016). A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer. OncoTarget. ISSN 1949-2553. 7(24), s. 37250–37259. doi: 10.18632/oncotarget.9363.
  • Lund-Iversen, Marius; Kotanska-Grøholt, Krystyna; Helland, Åslaug; Borgen, Elin & Brustugun, Odd Terje (2015). NUT expression in primary lung tumours. Diagnostic Pathology. ISSN 1746-1596. 10:156. doi: 10.1186/s13000-015-0395-9.
  • Darabi, Hatef; McCue, Karen; Beesley, Jonathan; Michailidou, Kyriaki; Nordgard, Silje H. & Kar, Siddhartha [Vis alle 129 forfattere av denne artikkelen] (2015). Polymorphisms in a putative enhancer at the 10q21.2 breast cancer risk locus regulate NRBF2 expression. American Journal of Human Genetics. ISSN 0002-9297. 97(1), s. 22–34. doi: 10.1016/j.ajhg.2015.05.002.
  • Fernandez-Cuesta, Lynnette; Sun, Ruping; Menon, Roopika; George, Julie; Lorenz, Susanne & Meza, Leonardo Zepeda [Vis alle 40 forfattere av denne artikkelen] (2015). Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data. Genome Biology. ISSN 1465-6906. 16:7. doi: 10.1186/s13059-014-0558-0.
  • Witek, Barbara; El Wakil, Abeer; Nord, Christoffer; Ahlgren, Ulf; Eriksson, Maria & Vernersson-Lindahl, Emma [Vis alle 10 forfattere av denne artikkelen] (2015). Targeted disruption of ALK reveals a potential role in hypogonadotropic hypogonadism. PLOS ONE. ISSN 1932-6203. 10(5). doi: 10.1371/journal.pone.0123542.
  • Syljuåsen, Randi G.; Hasvold, Grete; Hauge, Sissel & Helland, Åslaug (2015). Targeting lung cancer through inhibition of checkpoint kinases. Frontiers in Genetics. ISSN 1664-8021. 6. doi: 10.3389/fgene.2015.00070.
  • Potapenko, Ivan Olegovich; Luders, Torben; Russnes, Hege Elisabeth Giercksky; Helland, Åslaug; Sørlie, Therese & Kristensen, Vessela N. [Vis alle 10 forfattere av denne artikkelen] (2015). Glycan-related gene expression signatures in breast cancer subtypes; relation to survival. Molecular Oncology. ISSN 1574-7891. 9(4), s. 861–876. doi: 10.1016/j.molonc.2014.12.013.
  • Dønnem, Tom; Hald, Sigurd; Paulsen, Erna-Elise; Richardsen, Elin; Al-Saad, Samer & Kilvær, Thomas Karsten [Vis alle 20 forfattere av denne artikkelen] (2015). Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer. Clinical Cancer Research. ISSN 1078-0432. 21(11), s. 2635–2643. doi: 10.1158/1078-0432.CCR-14-1905.
  • Bjaanæs, Maria Moksnes; Nilsen, Gro; Solberg, Steinar; Brustugun, Odd Terje; Lingjærde, Ole Christian & Helland, Åslaug (2015). Whole-genome copy number analyses of NSCLC tumors reveal aberrations associated with EGFR mutations and may have prognostic impact. Journal of Thoracic Oncology. ISSN 1556-0864. 10(9), s. S581–S582.
  • Arnesen, Marius Røthe; Knudtsen, Ingerid Skjei; Rekstad, Bernt Louni; Eilertsen, Karsten; Dale, Einar & Bruheim, Kjersti [Vis alle 10 forfattere av denne artikkelen] (2015). Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps. Acta Oncologica. ISSN 0284-186X. 54(9), s. 1607–1613. doi: 10.3109/0284186X.2015.1061690.
  • Fleischer, Thomas; Frigessi, Arnoldo; Johnson, Kevin C.; Edvardsen, Hege; Touleimat, Nizar & Klajic, Jovana [Vis alle 15 forfattere av denne artikkelen] (2014). Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biology. ISSN 1465-6906. 15. doi: 10.1186/s13059-014-0435-x. Fulltekst i vitenarkiv
  • Brustugun, Odd Terje & Helland, Åslaug (2014). Rapid reduction in the incidence of cancer of unknown primary. A population-based study. Acta Oncologica. ISSN 0284-186X. 53(1), s. 134–137. doi: 10.3109/0284186X.2013.783230.
  • Halvorsen, Ann Rita; Helland, Åslaug; Fleischer, Thomas; Haug, Karen Marie; Grenaker, Grethe Irene & Nebdal, Daniel J.H. [Vis alle 14 forfattere av denne artikkelen] (2014). Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy. International Journal of Cancer. ISSN 0020-7136. 135(9), s. 2085–2095. doi: 10.1002/ijc.28862.
  • Bjaanæs, Maria Moksnes; Halvorsen, Ann Rita; Solberg, Steinar; Jørgensen, Lars Hilmar; Dragani, Tomasso A. & Galvan, Antonella [Vis alle 13 forfattere av denne artikkelen] (2014). Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. International Journal of Cancer. ISSN 0020-7136. 135(8), s. 1812–1821. doi: 10.1002/ijc.28828.
  • Saldova, Radka; Asadi Shehni, Akram; Haakensen, Vilde Drageset; Steinfeld, Israel; Hilliard, Mark & Kifer, Ilona [Vis alle 10 forfattere av denne artikkelen] (2014). Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC. Journal of Proteome Research. ISSN 1535-3893. 13(5), s. 2314–2327. doi: 10.1021/pr401092y.
  • Fernandez-Cuesta, Lynnette; Peifer, Martin; Lu, Xin; Sun, Ruping; Ozretic, Luka & Seidel, Danila [Vis alle 46 forfattere av denne artikkelen] (2014). Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nature Communications. ISSN 2041-1723. 27(5). doi: 10.1038/ncomms4518.
  • Sagerup, Camilla Maria Troøien; Nymoen, Dag Andre; Halvorsen, Ann Rita; Lund-Iversen, Marius; Helland, Åslaug & Brustugun, Odd Terje (2014). Human papilloma virus detection and typing in 334 lung cancer patients. Acta Oncologica. ISSN 0284-186X. 53(7), s. 952–957. doi: 10.3109/0284186X.2013.879608.

Se alle arbeider i Cristin

  • Brustugun, Odd Terje; Sørhaug, Sveinung; Grønberg, Bjørn Henning; Aanerud, Marianne; Al-Zubaydi, Mohammed Modar & Fjellbirkeland, Lars [Vis alle 13 forfattere av denne artikkelen] (2020). Lungekreft: Forbedret prognose gir kapasitetsutfordringer. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 140(5). doi: 10.4045/tidsskr.20.0014.
  • Berg, Janna; Lindberg, Morten; Bengtson, May-Bente; Brustugun, Odd Terje & Helland, Åslaug (2019). The Neutrophil and Platelet to Lymphocyte Ratios and Glasgow Prognostic Score as a Predictor for Relapse After Stereotactic Radiation for Lung Cancer. Journal of Thoracic Oncology. ISSN 1556-0864. 14. doi: 10.1016/j.jtho.2019.08.2457.
  • Abravan, Azadeh; Eide, Hanne Astrid; Helland, Åslaug & Malinen, Eirik (2019). Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy.
  • Damhuis, Ronald; Senan, Suresh; Khakwani, Aamir; Harden, Susan V.; Helland, Åslaug & Strand, Trond-Eirik (2019). Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries. Annals of Oncology. ISSN 0923-7534. 30, s. ii27–ii28. doi: 10.1093/annonc/mdz064.005.
  • Helland, Åslaug (2018). Banebrytende basalforskning. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 138(20). doi: 10.4045/tidsskr.18.0802.
  • Abravan, Azadeh; Eide, Hanne Astrid; Løndalen, Ayca; Helland, Åslaug & Malinen, Eirik (2018). Reduction in the bone marrow 18F-FDG uptake during thoracic radiotherapy of lung cancer. Radiotherapy and Oncology. ISSN 0167-8140. 127, s. 1164–1164.
  • Knudtsen, Ingerid Søberg Skjei; Eide, Hanne Astrid; Løndalen, Ayca; Abravan, Azadeh; Bogsrud, Trond & Sprauten, Mette [Vis alle 9 forfattere av denne artikkelen] (2017). 18FDG-PET/CT for assessing short-term therapy response of advanced non-small cell lung cancer patients.
  • Christoffersen, Thoralf; Helland, Åslaug; Engebråten, Olav; Straume, Oddbjørn & Guren, Tormod Kyrre (2016). Signalhemmere. I Dahl, Olav; Lehne, Gustav & Christoffersen, Thoralf (Red.), Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. Avdeling for farmakologi, Universitetet i Oslo. ISSN 978-82-992331-4-9. s. 282–328.
  • Abravan, Azadeh; Knudtsen, Ingerid Skjei; Eide, Hanne Astrid; Helland, Åslaug; van Luijk, Peter & Malinen, Eirik (2016). PET based response assessment of lung toxicity - assessment of two approaches for dose response. Radiotherapy and Oncology. ISSN 0167-8140. 119, s. 450–450.
  • Abravan, Azadeh; Knudtsen, Ingerid Skjei; Eide, Hanne; Brustugun, Odd Terje; Helland, Åslaug & Malinen, Eirik (2015). FDG-PET response in the normal lung for lung cancer patients receiving fractionated radiotherapy and erlotinib. Radiotherapy and Oncology. ISSN 0167-8140. 115, s. s634–s634. doi: 10.1016/S0167-8140%2815%2941159-4.
  • Abravan, Azadeh; Knudtsen, Ingerid Skjei; Eide, Hanne Astrid; Brustugun, Odd Terje; Helland, Åslaug & Malinen, Eirik (2014). Assessing glycolytic response in normal tissues following fractionated radiotherapy.
  • Knudtsen, Ingerid Skjei; Eide, Hanne; Løndalen, Ayca Muftuler; Bogsrud, Trond Velde; Brustugun, Odd Terje & Helland, Åslaug [Vis alle 7 forfattere av denne artikkelen] (2014). 18FDG-PET/CT evaluation of non-small cell lung cancer patients receiving radiotherapy and erlotinib. Radiotherapy and Oncology. ISSN 0167-8140. 111, s. 667–667.
  • Abravan, Azadeh; Knudtsen, Ingerid Skjei; Eide, Hanne; Brustugun, Odd Terje; Helland, Åslaug & Malinen, Eirik (2014). Monitoring changes in lung glucose metabolism for patients with lung cancer receiving thoracic irradiation. Radiotherapy and Oncology. ISSN 0167-8140. 111, s. 664–664.

Se alle arbeider i Cristin

Publisert 23. sep. 2016 12:14 - Sist endret 14. sep. 2017 13:24

Forskergrupper